BioMarin Pharmaceutical BMRN Balance Sheet

Income Statement

Quarter End	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	6B	6.06B	6.15B	6.26B	6.38B	6.43B	6.56B	6.76B
Total Current Assets	2.27B	2.39B	2.52B	2.68B	2.75B	2.84B	2.95B	2.96B
Cash and Equivalents	587.28M	605.44M	619.8M	761.52M	724.53M	580.07M	694.38M	785.41M
Total Non-Current Assets	4.76B	4.71B	4.68B	4.63B	4.69B	4.66B	4.68B	4.87B
Total Liabilities	1.73B	1.67B	1.64B	1.7B	1.77B	1.77B	1.78B	1.86B
Total Current Liabilities	539.82M	490.42M	464.73M	521.02M	588.88M	598.23M	597.23M	1.16B
Total Non-Current Liabilities	2.27B	2.26B	2.26B	2.26B	2.27B	2.26B	2.27B	1.29B
Common Equity	184k	185k	186k	186k	186k	188k	188k	188k
Retained Earnings	-925.69M	-804.89M	-777.23M	-788.95M	-789.2M	-738.35M	-682.31M	-641.93M

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	4.02B	4.63B	4.43B	4.69B	5.85B	6B	6.38B	6.84B
Total Current Assets	1.42B	2.21B	2.06B	1.94B	2.34B	2.27B	2.75B	2.96B
Cash and Equivalents	408.33M	598.03M	493.98M	437.45M	649.16M	587.28M	724.53M	755.13M
Total Non-Current Assets	2.77B	2.81B	2.97B	3.12B	4.11B	4.27B	4.6B	4.95B
Total Liabilities	1.26B	1.82B	1.46B	1.57B	1.74B	1.73B	1.77B	1.89B
Total Current Liabilities	439.31M	816.52M	523.24M	932.5M	492.55M	539.82M	588.88M	1.18B
Total Non-Current Liabilities	1.48B	1.82B	1.77B	1.13B	2.33B	2.27B	2.27B	1.31B
Total Equity	2.77B	2.81B	2.97B	3.12B	4.11B	4.27B	4.6B	4.95B
Common Equity	173k	176k	178k	180k	182k	184k	186k	189k
Retained Earnings	-1.52B	-1.64B	-1.69B	-1.72B	-861.61M	-925.69M	-789.2M	-621.55M